19962019
If you made any changes in Pure these will be visible here soon.

Research Output 1996 2019

Filter
Chapter
2017

Re-emerging antimetabolites with novel mechanism of action with respect to epigenetic regulation: Basic aspects

Sarkisjan, D., Steenbergen, R. D. M., Cloos, J. & Peters, G. J., 17 Apr 2017, Chemotherapy for Leukemia: Novel Drugs and Treatment. Springer Singapore, p. 311-326 16 p.

Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

2015

Flow cytometric MRD and leukemia stem cell frequency assessment to develop risk-stratified approaches in AML

Schuurhuis, G. J., Zeijlemaker, W. & Cloos, J., 2015, Annals of Hematology. G.J. Schuurhuis, Department of Hematology, Amsterdam, Netherlands: Springer Verlag, p. S49-S51 (Annals of Hematology; vol. 94).

Research output: Chapter in Book/Report/Conference proceedingChapterAcademicpeer-review

2014

Preclinical studies on the molecular basis of Bortezomib resistance and modalities to overcome resistance in hematological malignancies.

Cloos, J., Niewerth, D. & Jansen, G., 2014, Resistance to proteasome inhibitors in cancer. p. 181-204

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

2008

Proteasome and protease inhibitors

Franke, N. E., Vink, J., Cloos, J. & Kaspers, G. J. L., 2008, Innovative Leukemia and Lymfoma Therapy. New York: Informa Healthcare, p. 469-489

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic

Tyrosine phosphatases as new treatment targets in acute myeloid leukemia

Hubeek, I., Hoorweg-Nijman, J. J. G., Cloos, J. & Kaspers, G. J. L., 2008, Innovative Leukemia and Lymfoma Therapy. New York: Informa Healthcare, p. 449-468

Research output: Chapter in Book/Report/Conference proceedingChapterAcademic